We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOGZ:NASDAQDogness (International) Corporation Analysis

Data as of 2026-06-13 - not real-time

$1.18

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Dogness (International) Corporation is trading well below its 50‑day SMA and even its 20‑day SMA, signaling a bearish technical backdrop. The RSI sits in the mid‑50s, offering little momentum, while the MACD histogram is modestly positive but the MACD line remains under its signal, reinforcing a weak upside bias. Volatility is extreme (near 96% 30‑day swing) and beta is unusually low, indicating price swings are driven more by company‑specific risk than market moves. Fundamentally, the firm posts deep operating losses, negative cash flow, and a staggering debt‑to‑equity ratio above 16, with a max drawdown approaching 97%, suggesting a fragile balance sheet. Despite a very low price‑to‑book (≈0.18) and a price‑to‑sales near parity, earnings are negative and there is no dividend, making the valuation more reflective of distress than hidden value. The combination of a bearish trend, high volatility, and severe financial weakness points to a high‑risk, short‑term downside scenario, while the ultra‑low valuation leaves a sliver of speculative upside for long‑term contrarian investors.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical positioning (price below 20‑day and 50‑day SMAs)
  • Extreme short‑term volatility and negative momentum
  • Severe earnings and cash‑flow deficits

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential for price stabilization near strong support
  • Continued balance‑sheet stress limiting upside
  • Uncertainty around any turnaround initiatives

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Deep discount to book value offering speculative upside
  • Persistent negative profitability and high leverage
  • Exposure to Chinese consumer discretionary cycles

Key Metrics & Analysis

Financial Health

Revenue Growth-36.20%
Profit Margin-51.80%
ROE-9.96%
ROA-5.13%
Debt/Equity16.23
P/B Ratio0.2
Op. Cash Flow$-1984751
Free Cash Flow$-3826655

Technical Analysis

TrendBearish
RSI53.7
Support$0.81
Resistance$1.50
MA 20$1.08
MA 50$1.18
MA 200$6.79
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.19
Volatility95.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.